Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(4S)-4-[(2-oxohexadecanoyl)amino]nonanoic acid | - |
Homo sapiens | |
(5S)-5-[(2-oxohexadecanoyl)amino]decanoic acid | - |
Homo sapiens | |
(6Z,9Z,12Z,15Z)-1,1,1-trifluorohenicosa-6,9,12,15-tetraen-2-one | - |
Homo sapiens | |
1,1,1,2,2-pentafluoro-5-(4-hexyloxy-phenyl)-pentan-3-one | - |
Homo sapiens | |
1,1,1,2,2-pentafluoro-7-phenyl-heptan-3-one | a selective inhibitor of GVIA iPLA2 | Homo sapiens | |
1,1,1,2,2-pentafluoro-8-phenyl-octan-3-one | - |
Homo sapiens | |
1,1,1,2,2-pentafluoro-9-phenyl-nonan-3-one | - |
Homo sapiens | |
1,1,1,2,2-pentafluoro-octadecan-3-one | - |
Homo sapiens | |
1,1,1,3,3-pentafluoro-6-phenyl-hexane-2,2-diol | - |
Homo sapiens | |
1,1,1,3-tetrafluoro-heptadecan-2-one | - |
Homo sapiens | |
1,1,1-trifluoro-4-(4-hexyloxy-phenyl)-butan-2-one | - |
Homo sapiens | |
1,1,1-trifluoro-6-(4-hexyloxy-phenyl)-hexan-2-one | - |
Homo sapiens | |
1,1,1-trifluoro-6-phenylhexan-2-one | - |
Homo sapiens | |
1,1,1-trifluoro-7-phenylheptan-2-one | - |
Homo sapiens | |
1,1,1-trifluoro-8-phenyloctan-2-one | - |
Homo sapiens | |
1,1,1-trifluoroheptadecan-2-one | - |
Homo sapiens | |
1-[3-[4-(decyloxy)phenoxy]-2-oxopropyl]-3-(methoxycarbonyl)-1H-indole-5-carboxylic acid | - |
Homo sapiens | |
4-(4-benzyloxy-phenyl)-1,1,1-trifluoro-butan-2-one | - |
Homo sapiens | |
4-(4-decyloxy-phenyl)-1,1,1-trifluoro-butan-2-one | - |
Homo sapiens | |
4-[(2-oxohexadecanoyl)amino]butanoic acid | - |
Homo sapiens | |
4-[2-[5-chloro-2-(2-[[(3,4-dichlorobenzyl)sulfonyl]amino]ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]ethoxy]benzoic acid | - |
Homo sapiens | |
4-[3-[5-chloro-2-(2-[[(3,4-dichlorobenzyl)sulfonyl]amino]ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl]benzoic acid | - |
Homo sapiens | |
4-[4-[2-([2-[bis(4-chlorophenyl)methoxy]ethyl]sulfonyl)ethoxy]phenyl]-1,1,1-trifluorobutan-2-one | - |
Homo sapiens | |
6-(4-decyloxy-phenyl)-1,1,1-trifluoro-hexan-2-one | - |
Homo sapiens | |
ethyl 4-[(2-oxohexadecanoyl)amino]butanoate | - |
Homo sapiens | |
additional information | synthesis of fluoroketone inhibitors and inhibitory effects against isozymes group IVA cytosolic phospholipase A2, , group V secreted phospholipase A2, and group VIA calcium-independent phospholipase A2, overview. Trifluoromethyl ketone analogues of arachidonic and palmitic acids also inhibit GVIA iPLA2 | Homo sapiens | |
N-[[(2S,4R)-1-([2-[(2,4-difluorophenyl)carbonyl]phenyl]carbonyl)-4-(tritylsulfanyl)pyrrolidin-2-yl]methyl]-4-[(Z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzamide | - |
Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
extracellular | the enzyme is secreted | Homo sapiens | - |
- |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
additional information | the enzyme is Ca2+-independent | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
GIVA cPLA2 | - |
Homo sapiens |
group IVA cPLA2 | - |
Homo sapiens |
group IVA cytosolic phospholipase A2 | - |
Homo sapiens |
group V secreted phospholipase A2 | - |
Homo sapiens |
group VIA calcium-independent phospholipase A | - |
Homo sapiens |
GV sPLA2 | - |
Homo sapiens |
GVIA iPLA2 | - |
Homo sapiens |
phospholipase A2 | - |
Homo sapiens |